This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grant, R. S.
Right arrow Articles by Kapoor, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grant, R. S.
Right arrow Articles by Kapoor, V.

 Previous Article  |  Next Article 

Journal of Virology, May 2000, p. 4110-4115, Vol. 74, No. 9
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Induction of Indolamine 2,3-Dioxygenase in Primary Human Macrophages by Human Immunodeficiency Virus Type 1 Is Strain Dependent

Ross S. Grant,1 Hassan Naif,2,* Sophie J. Thuruthyil,1 Najla Nasr,2 Tamantha Littlejohn,3 Osamu Takikawa,3 and Vimal Kapoor1,*

School of Physiology and Pharmacology, Faculty of Medicine, University of New South Wales, Sydney 2052,1 Centre for Virus Research, University of Sydney, Westmead Hospital, Westmead 2145,2 and Australian Cataract Research Foundation, University of Wollongong, Wollongong 2522,3 New South Wales, Australia

Received 7 June 1999/Accepted 28 January 2000

Increased kynurenine pathway metabolism has been implicated in the etiology of AIDS dementia complex (ADC). The rate-limiting enzyme for this pathway is indolamine 2,3-dioxygenase (IDO). We tested the efficacy of different strains of human immunodeficiency virus type 1 (HIV1-BaL, HIV1-JRFL, and HIV1-631) to induce IDO in cultured human monocyte-derived macrophages (MDM). A significant increase in both IDO protein and kynurenine synthesis was observed after 48 h in MDM infected with the brain-derived HIV-1 isolates, laboratory-adapted (LA) HIV1-JRFL, and primary isolate HIV1-631. In contrast, almost no kynurenine production or IDO protein was evident in MDM infected with the highly replicating macrophage-tropic LA strain HIV1-BaL. The induction of IDO and kynurenine synthesis by HIV1-JRFL and HIV1-631 declined to baseline levels by day 8 postinfection. Abundant HIV-1 replication did not reduce the ability of exogenous gamma interferon (IFN-gamma ) to induce IDO and kynurenine synthesis in HIV-infected MDM. The addition of anti-IFN-gamma antibody to MDM infected with HIV1-JRFL resulted in an absence of detectable IDO protein after 48 h and a decrease of 64% ± 1% in supernatant kynurenine concentration. Together, these results indicate that only selected strains of HIV-1 are capable of inducing IDO synthesis and subsequent kynurenine metabolism in MDM. The induction of IDO, while apparently independent of replication capacity, appears to be mediated by a transient production of IFN-gamma in MDM responding to the initial infection with selected strains of HIV-1.


* Corresponding author. Mailing address for V. Kapoor: School of Physiology and Pharmacology, Faculty of Medicine, University of New South Wales, Sydney 2052, Australia. Phone: 61-2 93853741. Fax: 61-2 93851099. E-mail: V.Kapoor{at}unsw.edu.au. Mailing address for H. Naif: Centre for Virus Research, University of Sydney, Westmead Hospital, Westmead 2145, Australia. Phone: 61-2 98456311. Fax: 61-2 98458300. E-mail: hassann{at}westgate.wh.usyd.edu.au.


Journal of Virology, May 2000, p. 4110-4115, Vol. 74, No. 9
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Boasso, A., Vaccari, M., Fuchs, D., Hardy, A. W., Tsai, W.-P., Tryniszewska, E., Shearer, G. M., Franchini, G. (2009). Combined Effect of Antiretroviral Therapy and Blockade of IDO in SIV-Infected Rhesus Macaques. J. Immunol. 182: 4313-4320 [Abstract] [Full Text]  
  • Suh, H.-S., Zhao, M.-L., Rivieccio, M., Choi, S., Connolly, E., Zhao, Y., Takikawa, O., Brosnan, C. F., Lee, S. C. (2007). Astrocyte Indoleamine 2,3-Dioxygenase Is Induced by the TLR3 Ligand Poly(I:C): Mechanism of Induction and Role in Antiviral Response. J. Virol. 81: 9838-9850 [Abstract] [Full Text]  
  • Braun, D., Longman, R. S., Albert, M. L. (2005). A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood 106: 2375-2381 [Abstract] [Full Text]  
  • Potula, R., Poluektova, L., Knipe, B., Chrastil, J., Heilman, D., Dou, H., Takikawa, O., Munn, D. H., Gendelman, H. E., Persidsky, Y. (2005). Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis. Blood 106: 2382-2390 [Abstract] [Full Text]  
  • Obojes, K., Andres, O., Kim, K. S., Daubener, W., Schneider-Schaulies, J. (2005). Indoleamine 2,3-Dioxygenase Mediates Cell Type-Specific Anti-Measles Virus Activity of Gamma Interferon. J. Virol. 79: 7768-7776 [Abstract] [Full Text]  
  • Staniszewska, M. M., Nagaraj, R. H. (2005). 3-Hydroxykynurenine-mediated Modification of Human Lens Proteins: STRUCTURE DETERMINATION OF A MAJOR MODIFICATION USING A MONOCLONAL ANTIBODY. J. Biol. Chem. 280: 22154-22164 [Abstract] [Full Text]  
  • Andersson, J., Boasso, A., Nilsson, J., Zhang, R., Shire, N. J., Lindback, S., Shearer, G. M., Chougnet, C. A. (2005). Cutting Edge: The Prevalence of Regulatory T Cells in Lymphoid Tissue Is Correlated with Viral Load in HIV-Infected Patients. J. Immunol. 174: 3143-3147 [Abstract] [Full Text]  
  • Boasso, A., Herbeuval, J.-P., Hardy, A. W., Winkler, C., Shearer, G. M. (2005). Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells. Blood 105: 1574-1581 [Abstract] [Full Text]  
  • Valle, M., Price, R. W., Nilsson, A., Heyes, M., Verotta, D. (2004). CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy. Brain 127: 1047-1060 [Abstract] [Full Text]  
  • Mellor, A. L., Munn, D. H. (2003). Tryptophan Catabolism and Regulation of Adaptive Immunity. J. Immunol. 170: 5809-5813 [Full Text]  
  • Burudi, E. M. E., Marcondes, M. C. G., Watry, D. D., Zandonatti, M., Taffe, M. A., Fox, H. S. (2002). Regulation of Indoleamine 2,3-Dioxygenase Expression in Simian Immunodeficiency Virus-Infected Monkey Brains. J. Virol. 76: 12233-12241 [Abstract] [Full Text]  
  • Terness, P., Bauer, T. M., Rose, L., Dufter, C., Watzlik, A., Simon, H., Opelz, G. (2002). Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase-expressing Dendritic Cells: Mediation of Suppression by Tryptophan Metabolites. JEM 196: 447-457 [Abstract] [Full Text]